Harrison Bai
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Intelligence | 15 | 2025 | 389 | 3.770 |
Why?
| | Image Processing, Computer-Assisted | 14 | 2026 | 794 | 3.680 |
Why?
| | Magnetic Resonance Imaging | 33 | 2026 | 3980 | 2.790 |
Why?
| | Machine Learning | 11 | 2025 | 596 | 2.640 |
Why?
| | Positron Emission Tomography Computed Tomography | 4 | 2025 | 122 | 2.320 |
Why?
| | Image Interpretation, Computer-Assisted | 7 | 2026 | 297 | 2.250 |
Why?
| | Brain Neoplasms | 24 | 2024 | 1338 | 2.230 |
Why?
| | Glioma | 18 | 2022 | 432 | 2.070 |
Why?
| | Kidney Neoplasms | 6 | 2025 | 421 | 1.910 |
Why?
| | Liver Neoplasms | 8 | 2023 | 787 | 1.730 |
Why?
| | Tomography, X-Ray Computed | 16 | 2025 | 2791 | 1.710 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2023 | 379 | 1.490 |
Why?
| | Carcinoma, Renal Cell | 5 | 2021 | 233 | 1.450 |
Why?
| | Radiologists | 3 | 2021 | 61 | 1.350 |
Why?
| | Diagnostic Imaging | 2 | 2025 | 342 | 1.110 |
Why?
| | Urea | 2 | 2025 | 85 | 1.080 |
Why?
| | Humans | 146 | 2026 | 147306 | 1.080 |
Why?
| | Prostatic Neoplasms | 2 | 2025 | 986 | 1.030 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 387 | 0.970 |
Why?
| | Coronavirus Infections | 3 | 2020 | 378 | 0.970 |
Why?
| | Retrospective Studies | 41 | 2025 | 17561 | 0.940 |
Why?
| | Lysine | 2 | 2025 | 305 | 0.940 |
Why?
| | Chemoembolization, Therapeutic | 2 | 2023 | 89 | 0.920 |
Why?
| | Algorithms | 13 | 2026 | 1868 | 0.920 |
Why?
| | Bayes Theorem | 3 | 2025 | 428 | 0.890 |
Why?
| | Cerebellar Neoplasms | 3 | 2022 | 177 | 0.850 |
Why?
| | Stroke | 6 | 2022 | 1287 | 0.850 |
Why?
| | Multimodal Imaging | 2 | 2025 | 138 | 0.850 |
Why?
| | Aged | 45 | 2025 | 26516 | 0.840 |
Why?
| | Lung Neoplasms | 6 | 2023 | 2679 | 0.790 |
Why?
| | Neoplasms | 5 | 2025 | 2946 | 0.770 |
Why?
| | Radiography, Thoracic | 2 | 2021 | 173 | 0.750 |
Why?
| | Middle Aged | 49 | 2025 | 36821 | 0.750 |
Why?
| | Betacoronavirus | 3 | 2020 | 288 | 0.750 |
Why?
| | Computed Tomography Angiography | 5 | 2025 | 153 | 0.740 |
Why?
| | Pulmonary Embolism | 4 | 2026 | 246 | 0.740 |
Why?
| | Medulloblastoma | 2 | 2022 | 215 | 0.720 |
Why?
| | Female | 77 | 2025 | 80081 | 0.720 |
Why?
| | Biomedical Research | 2 | 2022 | 723 | 0.720 |
Why?
| | Decision Support Systems, Clinical | 1 | 2026 | 278 | 0.720 |
Why?
| | Osteoarthritis, Knee | 2 | 2016 | 284 | 0.720 |
Why?
| | Databases, Factual | 13 | 2024 | 1504 | 0.700 |
Why?
| | Radiography | 4 | 2022 | 862 | 0.700 |
Why?
| | Male | 69 | 2025 | 73954 | 0.680 |
Why?
| | Bone Neoplasms | 2 | 2021 | 272 | 0.670 |
Why?
| | ROC Curve | 5 | 2026 | 626 | 0.660 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2022 | 149 | 0.660 |
Why?
| | Astrocytoma | 3 | 2018 | 131 | 0.660 |
Why?
| | Ovarian Cysts | 1 | 2020 | 6 | 0.650 |
Why?
| | Awards and Prizes | 1 | 2022 | 72 | 0.650 |
Why?
| | Cholangiocarcinoma | 1 | 2022 | 110 | 0.650 |
Why?
| | Prognosis | 15 | 2025 | 4384 | 0.640 |
Why?
| | Radiology | 2 | 2021 | 176 | 0.640 |
Why?
| | Bile Duct Neoplasms | 1 | 2022 | 133 | 0.640 |
Why?
| | Data Anonymization | 1 | 2020 | 1 | 0.630 |
Why?
| | Isocitrate Dehydrogenase | 6 | 2019 | 72 | 0.600 |
Why?
| | Stents | 3 | 2019 | 570 | 0.590 |
Why?
| | Head | 2 | 2020 | 127 | 0.590 |
Why?
| | Tibial Arteries | 1 | 2019 | 14 | 0.580 |
Why?
| | Brain Ischemia | 2 | 2022 | 362 | 0.580 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 4 | 2021 | 1195 | 0.580 |
Why?
| | Severity of Illness Index | 4 | 2025 | 2974 | 0.580 |
Why?
| | Oligodendroglioma | 2 | 2016 | 15 | 0.580 |
Why?
| | Biopsy | 5 | 2018 | 1093 | 0.570 |
Why?
| | Limb Salvage | 1 | 2019 | 75 | 0.560 |
Why?
| | Parkinson Disease | 1 | 2025 | 613 | 0.560 |
Why?
| | Ischemia | 2 | 2019 | 424 | 0.550 |
Why?
| | Peripheral Vascular Diseases | 1 | 2019 | 105 | 0.550 |
Why?
| | Aged, 80 and over | 21 | 2025 | 8432 | 0.540 |
Why?
| | Arteriovenous Malformations | 1 | 2018 | 34 | 0.540 |
Why?
| | Dizziness | 2 | 2016 | 101 | 0.540 |
Why?
| | Liver Diseases | 1 | 2021 | 307 | 0.530 |
Why?
| | Sensitivity and Specificity | 6 | 2025 | 2017 | 0.530 |
Why?
| | Blood Vessel Prosthesis | 1 | 2018 | 141 | 0.510 |
Why?
| | Pulmonary Veins | 1 | 2018 | 112 | 0.500 |
Why?
| | Diagnosis, Differential | 7 | 2020 | 1518 | 0.500 |
Why?
| | Neoplasm Grading | 8 | 2020 | 313 | 0.490 |
Why?
| | Polyarteritis Nodosa | 1 | 2016 | 11 | 0.490 |
Why?
| | Brain | 9 | 2026 | 3009 | 0.490 |
Why?
| | Early Diagnosis | 2 | 2025 | 254 | 0.480 |
Why?
| | Polymyalgia Rheumatica | 1 | 2015 | 3 | 0.470 |
Why?
| | Rotator Cuff | 1 | 2016 | 61 | 0.460 |
Why?
| | Unsupervised Machine Learning | 2 | 2026 | 23 | 0.460 |
Why?
| | Whole Body Imaging | 1 | 2015 | 29 | 0.460 |
Why?
| | Adult | 36 | 2025 | 41406 | 0.460 |
Why?
| | Proportional Hazards Models | 10 | 2021 | 1344 | 0.460 |
Why?
| | Prednisolone | 1 | 2015 | 67 | 0.460 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2018 | 229 | 0.450 |
Why?
| | Patella | 1 | 2015 | 30 | 0.450 |
Why?
| | Vertigo | 1 | 2016 | 55 | 0.450 |
Why?
| | Glutamate Carboxypeptidase II | 2 | 2025 | 8 | 0.440 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2014 | 1 | 0.440 |
Why?
| | Physical Examination | 1 | 2016 | 245 | 0.440 |
Why?
| | Cerebrovascular Disorders | 1 | 2016 | 106 | 0.430 |
Why?
| | Diagnostic Errors | 1 | 2016 | 182 | 0.430 |
Why?
| | Postoperative Care | 2 | 2019 | 299 | 0.430 |
Why?
| | Rare Diseases | 1 | 2015 | 116 | 0.430 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2014 | 16 | 0.430 |
Why?
| | Lower Extremity | 1 | 2019 | 452 | 0.430 |
Why?
| | Knee Joint | 2 | 2016 | 439 | 0.430 |
Why?
| | Antigens, Surface | 2 | 2025 | 155 | 0.420 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 3 | 2025 | 122 | 0.420 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 599 | 0.410 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 269 | 0.400 |
Why?
| | Thrombolytic Therapy | 1 | 2015 | 165 | 0.400 |
Why?
| | Skin Neoplasms | 5 | 2018 | 865 | 0.400 |
Why?
| | Genomics | 2 | 2016 | 839 | 0.400 |
Why?
| | Radiology Information Systems | 2 | 2025 | 35 | 0.390 |
Why?
| | Endovascular Procedures | 1 | 2018 | 395 | 0.380 |
Why?
| | Chordoma | 3 | 2018 | 17 | 0.380 |
Why?
| | Positron-Emission Tomography | 3 | 2022 | 344 | 0.370 |
Why?
| | Radiation Injuries | 2 | 2025 | 149 | 0.370 |
Why?
| | Neoplasm Staging | 7 | 2021 | 1492 | 0.370 |
Why?
| | Chromosome Deletion | 3 | 2018 | 127 | 0.360 |
Why?
| | Young Adult | 19 | 2025 | 14437 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2015 | 288 | 0.360 |
Why?
| | Pulmonary Artery | 1 | 2018 | 1132 | 0.360 |
Why?
| | Tumor Burden | 4 | 2022 | 327 | 0.350 |
Why?
| | Cartilage, Articular | 1 | 2015 | 349 | 0.340 |
Why?
| | Clinical Competence | 1 | 2020 | 1260 | 0.340 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2025 | 104 | 0.340 |
Why?
| | Radiotherapy, Adjuvant | 4 | 2019 | 222 | 0.340 |
Why?
| | Neuroimaging | 4 | 2026 | 309 | 0.330 |
Why?
| | Adipose Tissue | 1 | 2015 | 646 | 0.330 |
Why?
| | Reproducibility of Results | 5 | 2025 | 3448 | 0.330 |
Why?
| | Treatment Outcome | 17 | 2024 | 11947 | 0.330 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2016 | 383 | 0.320 |
Why?
| | Adolescent | 21 | 2025 | 22826 | 0.320 |
Why?
| | Chromosomes, Human, Pair 19 | 4 | 2019 | 27 | 0.310 |
Why?
| | Chromosomes, Human, Pair 1 | 4 | 2019 | 82 | 0.310 |
Why?
| | Ultrasonography | 2 | 2026 | 795 | 0.300 |
Why?
| | Prospective Studies | 7 | 2025 | 8166 | 0.300 |
Why?
| | China | 3 | 2020 | 278 | 0.290 |
Why?
| | Angiography, Digital Subtraction | 2 | 2020 | 51 | 0.290 |
Why?
| | Meningeal Neoplasms | 2 | 2020 | 96 | 0.290 |
Why?
| | United States | 13 | 2026 | 16313 | 0.280 |
Why?
| | Ablation Techniques | 2 | 2019 | 36 | 0.280 |
Why?
| | Predictive Value of Tests | 8 | 2025 | 2133 | 0.280 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2022 | 165 | 0.280 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2025 | 35 | 0.280 |
Why?
| | Child | 14 | 2024 | 22980 | 0.270 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 2 | 2018 | 45 | 0.270 |
Why?
| | Lymphoproliferative Disorders | 2 | 2018 | 59 | 0.270 |
Why?
| | Mycosis Fungoides | 2 | 2018 | 64 | 0.260 |
Why?
| | Ependymoma | 2 | 2024 | 179 | 0.260 |
Why?
| | Cohort Studies | 9 | 2022 | 6099 | 0.260 |
Why?
| | Embolization, Therapeutic | 2 | 2020 | 246 | 0.260 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2019 | 429 | 0.260 |
Why?
| | Pneumonia | 3 | 2023 | 636 | 0.250 |
Why?
| | Gray Matter | 2 | 2024 | 97 | 0.250 |
Why?
| | Spinal Cord Neoplasms | 2 | 2018 | 41 | 0.240 |
Why?
| | Spinal Neoplasms | 2 | 2017 | 37 | 0.240 |
Why?
| | Biomarkers, Tumor | 5 | 2019 | 1339 | 0.240 |
Why?
| | Chemoradiotherapy | 2 | 2018 | 239 | 0.240 |
Why?
| | Kaplan-Meier Estimate | 5 | 2019 | 975 | 0.230 |
Why?
| | Diagnosis, Computer-Assisted | 3 | 2023 | 92 | 0.230 |
Why?
| | Follow-Up Studies | 10 | 2020 | 5478 | 0.230 |
Why?
| | Lymphoma, Extranodal NK-T-Cell | 2 | 2017 | 11 | 0.230 |
Why?
| | Head and Neck Neoplasms | 2 | 2023 | 569 | 0.220 |
Why?
| | Vena Cava Filters | 1 | 2026 | 69 | 0.220 |
Why?
| | Propensity Score | 4 | 2019 | 379 | 0.220 |
Why?
| | Aortic Rupture | 1 | 2025 | 28 | 0.220 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2025 | 59 | 0.220 |
Why?
| | Device Removal | 1 | 2026 | 149 | 0.220 |
Why?
| | Hydrocephalus, Normal Pressure | 1 | 2024 | 3 | 0.220 |
Why?
| | Liver | 2 | 2026 | 1916 | 0.220 |
Why?
| | Survival Rate | 9 | 2019 | 2110 | 0.220 |
Why?
| | Contrast Media | 3 | 2023 | 500 | 0.210 |
Why?
| | Temporal Lobe | 1 | 2025 | 113 | 0.210 |
Why?
| | Hydrocephalus | 1 | 2025 | 114 | 0.210 |
Why?
| | Mutation | 6 | 2021 | 4130 | 0.200 |
Why?
| | Ethiodized Oil | 1 | 2023 | 10 | 0.200 |
Why?
| | Child, Preschool | 9 | 2024 | 12017 | 0.200 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 125 | 0.200 |
Why?
| | Thymus Neoplasms | 1 | 2023 | 30 | 0.200 |
Why?
| | Philadelphia | 2 | 2020 | 55 | 0.200 |
Why?
| | Disease Progression | 4 | 2025 | 2892 | 0.200 |
Why?
| | Cerium | 1 | 2023 | 14 | 0.200 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2025 | 168 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 76 | 0.190 |
Why?
| | Uncertainty | 1 | 2024 | 146 | 0.190 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2023 | 52 | 0.190 |
Why?
| | Delirium | 1 | 2024 | 106 | 0.190 |
Why?
| | Pandemics | 3 | 2020 | 1720 | 0.190 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 76 | 0.190 |
Why?
| | Survival Analysis | 6 | 2024 | 1386 | 0.180 |
Why?
| | Risk Factors | 7 | 2025 | 11017 | 0.180 |
Why?
| | Abdomen | 1 | 2023 | 142 | 0.180 |
Why?
| | Skin | 2 | 2017 | 759 | 0.180 |
Why?
| | Mohs Surgery | 2 | 2019 | 30 | 0.180 |
Why?
| | White Matter | 1 | 2024 | 170 | 0.180 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 57 | 0.180 |
Why?
| | Supervised Machine Learning | 1 | 2022 | 23 | 0.180 |
Why?
| | Time Factors | 5 | 2020 | 7173 | 0.180 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2022 | 63 | 0.180 |
Why?
| | Thrombectomy | 1 | 2022 | 79 | 0.170 |
Why?
| | Radiology, Interventional | 1 | 2022 | 49 | 0.170 |
Why?
| | Financing, Organized | 1 | 2022 | 36 | 0.170 |
Why?
| | Financing, Government | 1 | 2022 | 53 | 0.170 |
Why?
| | Research Support as Topic | 1 | 2022 | 83 | 0.170 |
Why?
| | Pain | 2 | 2018 | 794 | 0.170 |
Why?
| | Risk Assessment | 4 | 2021 | 3784 | 0.170 |
Why?
| | Rectal Neoplasms | 1 | 2023 | 159 | 0.170 |
Why?
| | Endometrium | 1 | 2021 | 64 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 980 | 0.170 |
Why?
| | Radiosurgery | 3 | 2019 | 400 | 0.170 |
Why?
| | Liver Function Tests | 1 | 2021 | 105 | 0.170 |
Why?
| | Severe Acute Respiratory Syndrome | 1 | 2020 | 19 | 0.160 |
Why?
| | Seizures | 2 | 2015 | 491 | 0.160 |
Why?
| | Insulinoma | 1 | 2020 | 30 | 0.160 |
Why?
| | Uterine Artery Embolization | 1 | 2020 | 9 | 0.160 |
Why?
| | Rhode Island | 1 | 2020 | 31 | 0.160 |
Why?
| | Kidney | 2 | 2025 | 1511 | 0.150 |
Why?
| | Disease-Free Survival | 5 | 2020 | 779 | 0.150 |
Why?
| | Brain Diseases | 1 | 2021 | 158 | 0.150 |
Why?
| | Necrosis | 1 | 2021 | 245 | 0.150 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2019 | 2 | 0.150 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2019 | 3 | 0.150 |
Why?
| | Arteriovenous Fistula | 1 | 2020 | 38 | 0.150 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2020 | 53 | 0.150 |
Why?
| | Leiomyoma | 1 | 2020 | 62 | 0.150 |
Why?
| | Anastomotic Leak | 1 | 2019 | 45 | 0.150 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 25 | 0.150 |
Why?
| | Motor Cortex | 1 | 2020 | 65 | 0.150 |
Why?
| | Colon | 1 | 2022 | 310 | 0.150 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 97 | 0.150 |
Why?
| | Uterine Neoplasms | 1 | 2020 | 98 | 0.150 |
Why?
| | Patient Admission | 1 | 2021 | 220 | 0.140 |
Why?
| | Cryosurgery | 1 | 2019 | 47 | 0.140 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 474 | 0.140 |
Why?
| | Hemangioblastoma | 1 | 2018 | 3 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 479 | 0.140 |
Why?
| | Nomograms | 3 | 2025 | 59 | 0.140 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2018 | 17 | 0.140 |
Why?
| | Neurofibroma, Plexiform | 1 | 2018 | 12 | 0.140 |
Why?
| | Osteolysis, Essential | 1 | 2018 | 2 | 0.140 |
Why?
| | Face | 1 | 2020 | 176 | 0.140 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 2018 | 34 | 0.140 |
Why?
| | Mesentery | 1 | 2018 | 44 | 0.140 |
Why?
| | Lung | 3 | 2021 | 4141 | 0.140 |
Why?
| | Polytetrafluoroethylene | 1 | 2018 | 24 | 0.140 |
Why?
| | Meningioma | 1 | 2019 | 88 | 0.140 |
Why?
| | Lymphoma, T-Cell | 1 | 2018 | 31 | 0.140 |
Why?
| | Radiography, Interventional | 1 | 2019 | 128 | 0.140 |
Why?
| | DNA Repair Enzymes | 1 | 2018 | 30 | 0.140 |
Why?
| | Carcinoma, Merkel Cell | 1 | 2018 | 16 | 0.140 |
Why?
| | Cumulative Trauma Disorders | 1 | 2018 | 30 | 0.130 |
Why?
| | Skull Base Neoplasms | 1 | 2018 | 30 | 0.130 |
Why?
| | Vascular Patency | 1 | 2018 | 122 | 0.130 |
Why?
| | Journal Impact Factor | 1 | 2018 | 29 | 0.130 |
Why?
| | Clavicle | 1 | 2018 | 38 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2019 | 167 | 0.130 |
Why?
| | Gastric Bypass | 1 | 2019 | 126 | 0.130 |
Why?
| | Lymphoma, T-Cell, Peripheral | 1 | 2017 | 20 | 0.130 |
Why?
| | Esophageal Neoplasms | 1 | 2022 | 351 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2021 | 312 | 0.130 |
Why?
| | Publications | 1 | 2018 | 47 | 0.130 |
Why?
| | Peritoneal Neoplasms | 1 | 2018 | 104 | 0.130 |
Why?
| | Histiocytosis | 1 | 2017 | 9 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2019 | 207 | 0.130 |
Why?
| | Subclavian Steal Syndrome | 1 | 2017 | 3 | 0.130 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2019 | 237 | 0.130 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 196 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2023 | 889 | 0.120 |
Why?
| | Biomarkers | 3 | 2023 | 4354 | 0.120 |
Why?
| | Nanoparticles | 1 | 2023 | 524 | 0.120 |
Why?
| | Insurance Coverage | 1 | 2018 | 248 | 0.120 |
Why?
| | Health Resources | 1 | 2018 | 133 | 0.120 |
Why?
| | Models, Statistical | 2 | 2025 | 677 | 0.120 |
Why?
| | Radiotherapy | 1 | 2017 | 210 | 0.120 |
Why?
| | RNA, Viral | 1 | 2020 | 695 | 0.120 |
Why?
| | False Positive Reactions | 1 | 2016 | 124 | 0.120 |
Why?
| | Hot Temperature | 1 | 2019 | 396 | 0.120 |
Why?
| | Toxoplasmosis, Cerebral | 1 | 2016 | 2 | 0.120 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2016 | 10 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1672 | 0.120 |
Why?
| | Pulmonary Circulation | 1 | 2018 | 434 | 0.120 |
Why?
| | Prosthesis Design | 1 | 2018 | 363 | 0.120 |
Why?
| | Brain Mapping | 2 | 2020 | 550 | 0.120 |
Why?
| | Spine | 1 | 2017 | 184 | 0.120 |
Why?
| | AIDS Dementia Complex | 1 | 2016 | 52 | 0.120 |
Why?
| | Hepatectomy | 1 | 2018 | 280 | 0.120 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2015 | 8 | 0.110 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 38 | 0.110 |
Why?
| | Insurance, Health | 1 | 2018 | 321 | 0.110 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2015 | 16 | 0.110 |
Why?
| | Cushing Syndrome | 1 | 2015 | 10 | 0.110 |
Why?
| | Hypoglycemia | 1 | 2020 | 489 | 0.110 |
Why?
| | Lymphoma | 1 | 2017 | 253 | 0.110 |
Why?
| | Central Nervous System Diseases | 1 | 2016 | 75 | 0.110 |
Why?
| | Epilepsy, Absence | 1 | 2015 | 12 | 0.110 |
Why?
| | Accessory Nerve Diseases | 1 | 2014 | 1 | 0.110 |
Why?
| | Hypoglossal Nerve Diseases | 1 | 2014 | 3 | 0.110 |
Why?
| | Chronic Disease | 1 | 2021 | 1845 | 0.110 |
Why?
| | Epilepsy | 2 | 2017 | 399 | 0.110 |
Why?
| | Central Nervous System Neoplasms | 1 | 2017 | 179 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2021 | 951 | 0.110 |
Why?
| | Abdominal Pain | 1 | 2015 | 149 | 0.100 |
Why?
| | Oxygen | 1 | 2020 | 998 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2017 | 627 | 0.100 |
Why?
| | Critical Illness | 1 | 2021 | 907 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2023 | 2231 | 0.100 |
Why?
| | Hypertension | 1 | 2023 | 1280 | 0.100 |
Why?
| | MicroRNAs | 2 | 2017 | 695 | 0.100 |
Why?
| | Liver Cirrhosis | 1 | 2016 | 289 | 0.100 |
Why?
| | Paresis | 1 | 2013 | 30 | 0.100 |
Why?
| | Patient Discharge | 1 | 2020 | 1002 | 0.100 |
Why?
| | Encephalitis | 1 | 2015 | 142 | 0.100 |
Why?
| | Oligodendroglia | 1 | 2016 | 198 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 50 | 0.100 |
Why?
| | Hydroa Vacciniforme | 1 | 2013 | 1 | 0.100 |
Why?
| | Puerperal Disorders | 1 | 2013 | 36 | 0.100 |
Why?
| | Periodicals as Topic | 1 | 2015 | 211 | 0.090 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2013 | 74 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2018 | 433 | 0.090 |
Why?
| | Infant, Newborn | 2 | 2025 | 6543 | 0.090 |
Why?
| | CD4 Antigens | 1 | 2013 | 137 | 0.090 |
Why?
| | Anticonvulsants | 1 | 2015 | 253 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2018 | 1166 | 0.090 |
Why?
| | Area Under Curve | 2 | 2024 | 334 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2020 | 947 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 464 | 0.080 |
Why?
| | Surgeons | 1 | 2016 | 342 | 0.080 |
Why?
| | HIV Infections | 2 | 2017 | 3235 | 0.080 |
Why?
| | Schizophrenia | 1 | 2015 | 489 | 0.080 |
Why?
| | Postpartum Period | 1 | 2013 | 379 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 1072 | 0.080 |
Why?
| | Craniotomy | 2 | 2020 | 84 | 0.070 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 367 | 0.070 |
Why?
| | Infant | 2 | 2020 | 10195 | 0.070 |
Why?
| | Pregnancy Complications | 1 | 2013 | 607 | 0.060 |
Why?
| | Incidence | 3 | 2021 | 2954 | 0.060 |
Why?
| | Age Factors | 3 | 2018 | 3372 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1550 | 0.050 |
Why?
| | Meningomyelocele | 1 | 2025 | 63 | 0.050 |
Why?
| | Aorta, Abdominal | 1 | 2025 | 52 | 0.050 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2024 | 44 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2018 | 1281 | 0.050 |
Why?
| | Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester | 1 | 2024 | 1 | 0.050 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1342 | 0.050 |
Why?
| | Adenocarcinoma | 2 | 2021 | 928 | 0.050 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2023 | 39 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 2001 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2016 | 3022 | 0.050 |
Why?
| | Stress, Mechanical | 1 | 2025 | 494 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 27 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 241 | 0.040 |
Why?
| | Rectum | 1 | 2023 | 183 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2025 | 587 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2025 | 873 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2023 | 293 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 502 | 0.040 |
Why?
| | Yttrium Radioisotopes | 1 | 2020 | 64 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 476 | 0.040 |
Why?
| | Gene Expression | 1 | 2025 | 1481 | 0.040 |
Why?
| | Color | 1 | 2020 | 81 | 0.040 |
Why?
| | Anal Canal | 1 | 2020 | 102 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2018 | 2017 | 0.040 |
Why?
| | Antioxidants | 1 | 2023 | 550 | 0.040 |
Why?
| | Automation | 1 | 2019 | 104 | 0.040 |
Why?
| | Electrocardiography | 1 | 2023 | 675 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 54 | 0.040 |
Why?
| | Sulfonamides | 1 | 2023 | 596 | 0.040 |
Why?
| | Observer Variation | 1 | 2020 | 358 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2019 | 180 | 0.040 |
Why?
| | Research | 1 | 2022 | 435 | 0.040 |
Why?
| | Body Composition | 1 | 2023 | 694 | 0.040 |
Why?
| | Fever | 1 | 2020 | 320 | 0.040 |
Why?
| | Perfusion | 1 | 2020 | 252 | 0.030 |
Why?
| | Drainage | 1 | 2019 | 189 | 0.030 |
Why?
| | Cranial Fossa, Posterior | 1 | 2018 | 20 | 0.030 |
Why?
| | Ki-1 Antigen | 1 | 2018 | 7 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2025 | 639 | 0.030 |
Why?
| | Neuroendoscopy | 1 | 2018 | 24 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2018 | 83 | 0.030 |
Why?
| | Qualitative Research | 1 | 2026 | 1735 | 0.030 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 1 | 2018 | 23 | 0.030 |
Why?
| | Societies, Medical | 1 | 2022 | 914 | 0.030 |
Why?
| | Neurosurgery | 1 | 2018 | 41 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2021 | 638 | 0.030 |
Why?
| | Age of Onset | 1 | 2019 | 568 | 0.030 |
Why?
| | Hospitalization | 2 | 2020 | 2496 | 0.030 |
Why?
| | Atlases as Topic | 1 | 2017 | 10 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 506 | 0.030 |
Why?
| | Datasets as Topic | 1 | 2017 | 121 | 0.030 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2017 | 21 | 0.030 |
Why?
| | Organ Specificity | 1 | 2018 | 310 | 0.030 |
Why?
| | Neck | 1 | 2017 | 109 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2223 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 150 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 528 | 0.030 |
Why?
| | Putamen | 1 | 2017 | 23 | 0.030 |
Why?
| | Extremities | 1 | 2017 | 144 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 891 | 0.030 |
Why?
| | Patients | 1 | 2018 | 184 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2142 | 0.030 |
Why?
| | Perioperative Period | 1 | 2016 | 71 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1084 | 0.030 |
Why?
| | Tyrosine | 1 | 2016 | 218 | 0.030 |
Why?
| | Pain Measurement | 1 | 2018 | 569 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2434 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2022 | 928 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 740 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2016 | 210 | 0.030 |
Why?
| | Bias | 1 | 2016 | 201 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 648 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 445 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 285 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 695 | 0.030 |
Why?
| | Ferrets | 1 | 2015 | 32 | 0.030 |
Why?
| | Genome | 1 | 2017 | 306 | 0.030 |
Why?
| | Hemodynamics | 1 | 2020 | 1127 | 0.030 |
Why?
| | Skull Base | 1 | 2014 | 55 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2016 | 512 | 0.030 |
Why?
| | Intracranial Hemorrhages | 1 | 2015 | 107 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 514 | 0.030 |
Why?
| | Medicaid | 1 | 2018 | 475 | 0.030 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2013 | 5 | 0.020 |
Why?
| | Cerebral Angiography | 1 | 2013 | 122 | 0.020 |
Why?
| | Sports | 1 | 2015 | 216 | 0.020 |
Why?
| | CD56 Antigen | 1 | 2013 | 34 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 170 | 0.020 |
Why?
| | Risk | 1 | 2015 | 927 | 0.020 |
Why?
| | Valine | 1 | 2013 | 83 | 0.020 |
Why?
| | Acyclovir | 1 | 2013 | 98 | 0.020 |
Why?
| | Medicare | 1 | 2018 | 915 | 0.020 |
Why?
| | Recurrence | 1 | 2016 | 1151 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2013 | 306 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2020 | 2054 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2136 | 0.020 |
Why?
| | Herpesvirus 4, Human | 1 | 2013 | 173 | 0.020 |
Why?
| | Prednisone | 1 | 2013 | 230 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 3029 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2013 | 201 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 590 | 0.020 |
Why?
| | Electroencephalography | 1 | 2015 | 570 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1730 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1379 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4605 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 7276 | 0.010 |
Why?
| | Animals | 1 | 2015 | 38417 | 0.010 |
Why?
|
|
Bai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|